Alnylam Pharmaceuticals, Inc.
Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
Last updated:
Abstract:
The invention relates methods of using RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1.
Status:
Grant
Type:
Utility
Filling date:
12 Jul 2018
Issue date:
1 Mar 2022